Maalat, Meraluna P.

HRN: 21-88-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2022
AMPICILLIN 1GM (VIAL)
09/11/2022
09/18/2022
IV
2G
Q6
PROMx 13H
Waiting Final Action 
09/11/2022
CEFUROXIME 500MG (TAB)
09/11/2022
09/17/2022
ORAL
500 Mg
BID
PROM
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: